Redcare Pharmacy report says EU drug shortages often stem from distribution gaps, not supply

By Public Technologies
  • Redcare Pharmacy published an expert report arguing Europe’s critical medicine shortages are often a distribution issue, not a supply issue.
  • Analysis tracked shortages for 49 critical medicines across six countries, highlighting mismatches where some markets run short despite EU availability elsewhere.
  • The report flags EU-wide cross-border e-prescriptions via MyHealth@EU as a potential route to shift dispensing across borders once fully available from Q1 2029.
  • It positions authorized online pharmacies connected to MyHealth@EU as a channel to route available stock to patients, supporting EHDS objectives.
  • Recommendations center on faster EHDS rollout, online pharmacy integration, harmonized e-prescription standards, and clearer reimbursement and governance frameworks.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redcare Pharmacy NV published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk